Difference between revisions of "Boehringer-Ingelheim"
(→Lobbying and PR firms) |
|||
Line 4: | Line 4: | ||
*[[Chambre Public Affairs]] | *[[Chambre Public Affairs]] | ||
− | ==Notes | + | ==Notes== |
<references/> | <references/> |
(→Lobbying and PR firms) |
|||
Line 4: | Line 4: | ||
*[[Chambre Public Affairs]] | *[[Chambre Public Affairs]] | ||
− | ==Notes | + | ==Notes== |
<references/> | <references/> |